[Anonīms (2007). Latvijas vēža registrs [Cancer Registry of Latvia]. Riga, Latvia (in Latvian).]Search in Google Scholar
[Anonymous (2002). Globocan 2002. International Agency for Research on Cancer. http://www-dep.iarc.fr/globocan/globocan.html]Search in Google Scholar
[Aretz, S., Stienen, D., Friedrichs, N., Stemmler, S., Uhlhaas, S., Rahner, N., Friedl, W. (2007). Somatic APC mosaicism: A frequent cause of familial adenomatous polyposis (FAP). Hum. Mutat., 28(10), 985-992.10.1002/humu.2054917486639]Search in Google Scholar
[Bartch, D.K., Kress, R., Sina-Frey, M., Grutzman, R., Gerdes, B., Pilarsky, C., Heise, J.V., Schulte, K.M., Ghadimi, M.B., Horstmann, O., Schmidt, J., Eisold, S., Hahn, S.A., Schulmann, K., Bock, W., Gress, T.M., Zugel, N., Prenzel, K., Messmann, H., Enlicher, E., Schneider, M., Ziegler, M., Schmiegel, K., Rothmund, M., Rieder, H. (2004). Epidemiology. Prevalence of familial pancreatic cancer in Germany. Int. J. Cancer, 110(6), 902-906.]Search in Google Scholar
[Bisgaard, M., Ripa, R., Bülow, S. (2004). Mutation analysis of the adenomatous polyposis coli (APC) gene in Danish patients with familial adenomatous polyposis (FAP). Human Mutation: Mutation in Brief, No. 705, http://www3.interscience.wiley.com/homepages/38515/pdf/mutation/705.pdf http://www3.interscience.wiley.com/homepages/38515/pdf/mutation/705.pdf10.1002/humu.923415108286]Search in Google Scholar
[Boltenberg, A., Furgyik, S., Kullander, S. (1990). Familial cancer agregation in cases of adenocarcinoma corporis uteri. Acta Obstet. Gynecol. Scand., 69, 249-258.10.3109/000163490090286892220348]Search in Google Scholar
[Bratt, O. (2000). Hereditary prostate cancer. BJU Int. 85(5), 588-98.10.1046/j.1464-410x.2000.00457.x10735934]Search in Google Scholar
[Bülow, S., Nielsen, T., Bülow, C., Bisgaard, M.L., Karlsen, L., Moesgaard, F. (1996). The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int. J. Colorectal Dis., 11(2), 88-91.]Search in Google Scholar
[Calin, G.A., Trapasso, F., Shimizu, M., Dumitru, C.D., Godwin, A.K., Ferracin, M., Bernardi, G., Rattan, S., Alder, H., Mabuchi, H., Overgaard, J., Mauro, F.R., Neuberg, D., Bullrich, F., Negrini, M., Croce, C.M. (2005). Familial cancer associated with a polymorphism in ARLTS1. New Engl. J. Med., 352, 1667-1676.10.1056/NEJMoa04228015843669]Search in Google Scholar
[Chapelle, A., de la (2004). Genetic predisposition to colorectal cancer. Nat. Rev. Cancer., 4(10), 769-780.10.1038/nrc145315510158]Search in Google Scholar
[Chiaro, M., Presciuttini, S., Bertacca, L., Zerbi, A., Longoni, B.M., Cipollini, G., Caligo, M.A., Boggi, U., Civitelli, V., Falconi, M., Pederzoli, P., Di Carlo, V., Cavallini, G., Mosca, F. (2005). Cancer risk among relatives of probands with pancreatic ductal adenocarcinoma. Offic. J. Int. HepatoPancreatoBiliary Assoc., 7(1), 76.]Search in Google Scholar
[Csokay, B., Tihomirova, L., Stengrevics, A., Sinicka, O., Olah, E. (1999). Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Hum. Mutat., 14, 92.]Search in Google Scholar
[Cybulski, C., Górski, B., Debniak, T., Gliniewicz, B., Mierzejewski, M., Masojc, B., Jakubowska, A., Matyjasik, J., Zlowocka, E., Sikorski, A., Narod, S.A., Lubinski, J. (2004). NBS1 is a prostate cancer susceptibility gene. Cancer Res., 64(4), 1215-1219.10.1158/0008-5472.CAN-03-250214973119]Search in Google Scholar
[Cybulski, C., Huzarski, T., Górski, B., Masojc, B., Mierzejewski, M., Debniak, T., Gliniewicz, B., Matyjasik, J., Zlowocka, E., Kurzawski, G., Sikorski, A., Posmyk, M., Szwiec, M., Czajka, R., Narod, S.A., Lubinski, J. (2004). A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res., 64(8), 2677-2679.10.1158/0008-5472.CAN-04-034115087378]Search in Google Scholar
[Cybulski, C., Górski, B., Gronwald, J., Huzarski, T., Byrski, T., Debniak, T., Jakubowska, A., Wokolorczyk, D., Gliniewicz, B., Sikorski, A., Stawicka, M., Godlewski, D., Kwias, Z., Antczak, A., Borkowski, T., Szwiec, M., Posmyk, M., Narod, S.A., Lubiński, J. (2008). BRCA1 mutations and prostate cancer in Poland. Eur. J. Cancer Prev., 17, 62-66.10.1097/CEJ.0b013e32809b4d2018090912]Search in Google Scholar
[Debniak, T., Scott, R.J., Huzarski, T., Byrski, T., Rozmiarek, A., Debniak, B., Gorski, B., Cybulski, C., Medrek, K., Masojc, B., Lener, M., Jaworowska, E., Oszutowska, D., Szymanska, A., Castaneda, J., Wetering, T., Suchy, J., Kurzawski, G., Oszurek, O., Narod, S., Lubinski, J. (2006). CDKN2A common variant and multi-organ cancer risk - a population-based study. Int. J. Cancer, 118(12), 3180-3182.10.1002/ijc.2176016395703]Search in Google Scholar
[Debniak, T., Cybulski, C., Kurzawski, G., Górski, B., Huzarski, T. (2006). Low-risk genes and multi-organ cancer risk in the Polish population. Hered. Cancer Clin. Pract., 4(1), 52-55.10.1186/1897-4287-4-1-52340192220223005]Search in Google Scholar
[Ford, D., Easton, D.F., Stratton, M., Narod, S., Goldgar, D. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Amer. J. Hum. Genet., 62(3), 676-689.10.1086/30174913769449497246]Search in Google Scholar
[Frank, B., Hemminki, K., Meindl, A., Wappenschmidt, B., Klaes, R., Schmutzler, R., Untch, M., Bugert, P., Bartram, C.R., Burwinkel, B. (2006). Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk. Int. J. Cancer, 118, 2505-2508.10.1002/ijc.2168716353159]Search in Google Scholar
[Fromont, G., Yacoub, M., Valeri, A., Mangin, P., Vallancien, G., Cancel-Tassin, G., Cussenot, O. (2008). Differential expression of genes related to androgen and estrogen metabolism in hereditary versus sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev., 17, 1505-1509.10.1158/1055-9965.EPI-07-277818559568]Search in Google Scholar
[Górski, B., Byrski, T., Huzarski, T. (2000). Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Amer. J. Hum. Genet., 66, 1963-1968.10.1086/302922137805110788334]Search in Google Scholar
[Gronwald, J., Huzarski, T., Oszurek, O., Janicka, A., Szymańska-Pasternak, J., Górski, B., Menkiszak, J., Rzepka-Górska, I., Lubiński, J. (2008). Hereditary breast and ovarian cancer. Hered. Cancer Clin. Pract., 6(2), 88-98.10.1186/1897-4287-6-2-88273578419804604]Search in Google Scholar
[Gronwald, J., Elsakob, P., Gorski, B., Lubinski, J. (2005). High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res. Treat., 94(2), 111-113.10.1007/s10549-005-5150-616261409]Search in Google Scholar
[Hahn, S.A., Greenhalf, B., Ellis, I., Sine-frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Campra, D., Grutzmann, R., Rehder, H., Rothmund, M., Schmiegel, W., Neoptolemos, J.P., Bartsch, D.K. (2003). BRCA2 germline mutations in familial pancreatic carcinoma. J. Natl. Cancer Ins., 95, 214-221.10.1093/jnci/95.3.21412569143]Search in Google Scholar
[Hughes, C., Murphy, A., Martin, C., Sheils, O., O'Leary, J. (2005). Molecular pathology of prostate cancer. J. Clin. Pathol., 58, 673-684.10.1136/jcp.2002.003954177071515976331]Search in Google Scholar
[Jarvinen, H.J. (1992). Epidemiology of familial adenomatous polyposis in Finland: Impact of family screening on the colorectal cancer rate and survival. Gut, 33(3), 357-360.10.1136/gut.33.3.35713738271314763]Search in Google Scholar
[Jacobi, C.E., Jonker, M.A., Nagelkerke, N., van Houwelingen, J., Bock, G.H. (2003). Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care. J. Med. Genet., 40(7), e83.10.1136/jmg.40.7.e83]Search in Google Scholar
[Jemal, A., Thomas, A., Murray, T., Thun, M. (2002). Cancer statistics. Ca. Cancer J. Clin., 52, 23-47.10.3322/canjclin.52.1.23]Search in Google Scholar
[John, E.M. (2004). The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res., 6(4), R375-389.10.1186/bcr801]Search in Google Scholar
[Kilpivaara, O., Laiho, L., Aaltonen, A., Nevanlinna, H. (2003). CHEK2 1100delC and colorectal cancer. J. Med. Genet., 40(10), 110.10.1136/jmg.40.10.e110]Search in Google Scholar
[Kurzawski, G., Suchy, J., Kladny, J., Grabowska, E., Jakubowska, A., Debniak, T., Cybulski, C., Kowalska, E., Szych, Z., Domagala, W., Scott, R.J., Lubinski, J. (2004). The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res. 64(5), 1604-1606.10.1158/0008-5472.CAN-03-3791]Search in Google Scholar
[Levy-Lahad, E. (1997). Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Amer. J. Hum. Genet., 60(5), 1059-1067.]Search in Google Scholar
[Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo M., Pukkala E., Hemminki, K. (2000). Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. New Engl. J. Med., 343, 78-85.10.1056/NEJM200007133430201]Search in Google Scholar
[Lynch, H.T., Lanspa, S., Smyrk, B.B., Watson, P., Lynch, J. (1991). Hereditary non-polyposis colorectal cancer (Lynch syndromes I and II) genetics, pathology, natural history and cancer control, Part I. Cancer Genet. Cytogenetic., 53, 143-160.10.1016/0165-4608(91)90093-A]Search in Google Scholar
[Martin, A.M., Blackwood, M.A., Antin-Ozerkis, D., Shih, H.A., Calzone, K., Colligon, T., Seal, S., Collins, N., Stratton, M.R., Weber, B.L., Nathanson, K.L. (2001). Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J. Clin. Oncol., 19(8), 2247-2253.10.1200/JCO.2001.19.8.2247]Search in Google Scholar
[Masojc, B., Mierzejewski, M., Cybulski, C., Wetering, T., Debniak, T., Gorski, B., Jaworowska, E., Tarnowska, C., Lenner, M., Scott, R.J., Lubinski, J. (2006). Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene. Breast Cancer Res. Treat., 99(1), 59-62.10.1007/s10549-006-9180-5]Search in Google Scholar
[Mecklin, J.-P., Jarvinen, H.I. (1991). Tumor spectrum in cancer-family syndroma. Cancer, 68, 1109-1112.10.1002/1097-0142(19910901)68:5<1109::AID-CNCR2820680535>3.0.CO;2-S]Search in Google Scholar
[Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Duerr, R., Achkar, R., Brant, S., Bayless, T., Kirschner, B., Hanauer, S., Nunez, G., Cho, J.H. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411(6837), 603-606.]Search in Google Scholar
[Oszurek, O., Gorski, B., Gronwald, J., Prosolow, Z., Uglanica, K., Murinow, A., Bobko, I., Norik, D., Byrski, T., Jakubowska, A., Lubinski, J. (2001). Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families. Clin. Genet., 60(6), 470-471.10.1034/j.1399-0004.2001.600611.x]Search in Google Scholar
[Ollikainen, M., Abdel-Rahman, W., Moisio, A., Lindroos, A., Kariola, R., Jarvela, I., Poyhonen, M., Butzow, R., Peltomaki, P. (2005). Molecular analysis of familial endometrial carcinoma: A manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome. J. Clin. Oncol., 23(21), 4609-4616.10.1200/JCO.2005.06.055]Search in Google Scholar
[Pohlreich, P. (2005). High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Breast Cancer Res., 7(5), R728-736.10.1186/bcr1282]Search in Google Scholar
[Rennert, H., Zeigler-Johnson, C., Addya, K., Finley, M., Walker, A., Spangler, E., Leonard, D., Wein, A., Malkowicz, S., Rebbeck, T. (2005). Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol. Biomarkers Prev., 14(4), 949-957.10.1158/1055-9965.EPI-04-0637]Search in Google Scholar
[Sandles, L.G. (1998). Familial endometrial adenocarcinoma. Clin. Obstet. Gynecol., 41, 167-171.10.1097/00003081-199803000-00023]Search in Google Scholar
[Santarosa, M., Liede, A., Aube, J., Finch, A., Kwan, E., Jack, E., Narod, S., Randall, S., Hugel, L., Clark, K. (1999). BRCA1 and BRCA2 genes: Role in hereditary breast and ovarian cancer in Italy. Int. J. Cancer, 83(1), 5-9.10.1002/(SICI)1097-0215(19990924)83:1<5::AID-IJC2>3.0.CO;2-U]Search in Google Scholar
[Sinicka, O., Stengrevics, A., Eglitis, J., Smite, D., Shomshteine, Z., Tihomirova, L. (2004). Ovarian cancer in Latvia is attributable to recurrent mutations in the BRCA1 gene. Acta Universitatis Latviensis. Biology, 676, 17-25.]Search in Google Scholar
[Suomi, R., Hakala, T., Pietila, A., Laminen, A., Mecklin, J.-P., Lehtovirta, P. (1995). Hereditary aspects of endometrial adenocarcinoma. J. Cancer, 62, 132-137.10.1002/ijc.2910620204]Search in Google Scholar
[Stacey, S.N., Sulem, P., Johannsson, O., Helgason, A., Gudmundsson, J., Kostic, J., Kristjansson, K., Sveinsson, T., Myrdal, G., Grimsson, H., Kong, A., Stefansson, K. (2006). The BARD1 Cys557Ser variant and breast cancer risk in Iceland. PLoS Med., 3(7), e217.10.1371/journal.pmed.0030217]Search in Google Scholar
[Thompson, D., Easton, D.F. (2002). Cancer incidence in BRCA1 mutation carriers. J. Natl. Cancer Inst., 94(18), 1358-1365.10.1093/jnci/94.18.1358]Search in Google Scholar
[Tikhomirova, L., Sinicka, O., Smite, D., Hodgson, S.V., Stengrevics, A. (2005). High prevalence of two BRCA1 mutations, 4154delA and 5382insC in Latvia. Fam. Cancer, 4, 77-84.10.1007/s10689-004-2758-3]Search in Google Scholar
[Vasen, H.F. (2001). Erfelijke tumoren. Richtlijnen voor diagnostiek en preventie. Stichting Opsporing Erfelijke Tumoren & Vereniging klinische Genetica Nederland Werkgroep Klinische Oncogenetica. 21.]Search in Google Scholar